Author

A. A. Dias

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. C. Oliveira· 1 shared A. C. Vicente Santos· 1 shared A. M. O. Gomes· 1 shared A. Machado· 1 shared C. H. Dumard· 1 shared C. O. da Silva· 1 shared C. P. Figueiredo· 1 shared E. M. Saraiva· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. C. Oliveira

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neutrophil Extracellular Traps contribute to the pathogenesis of leprosy type 2 reactions

C. O. da Silva, A. A. Dias, J. A. Nery, A. Machado, H. Ferreira, J. P. Santos, N. Nadaes, E. N. Sarno, E. M. Saraiva, V. Schmitz, M. C. V. Pessolani

This study investigates the role of neutrophil extracellular traps (NETs) in the pathogenesis of leprosy type 2 reactions and shows that thalidomide treatment reduces NET formation.

bioRxiv · Apr 8, 2019Immunology

Yellow Fever Vaccine Protects Resistant and Susceptible Mice Against Zika Virus Infection

A. C. Vicente Santos, F. H. Guedes-da-Silva, C. H. Dumard, V. N. S. Ferreira, I. P. S. da Costa, R. A. Machado, F. G. Q. Barros-Aragao, R. L. S. Neris, J. S. Dos-Santos, I. Assuncao-Miranda, C. P. Figueiredo, A. A. Dias, A. M. O. Gomes, H. L. de Matos Guedes, A. C. Oliveira, J. L. Silva

This study shows that the yellow fever vaccine (17DD) protects both resistant and susceptible mice against Zika virus infection, reducing mortality, viral load, and neurological impairment.

bioRxiv · Mar 29, 2019 · PreprintImmunology